Here we are, on the cusp of the midway point in a decade that has been, in global health and infectious diseases terms, a lot ...

In STAT's "jealousy list" for 2024, STAT staffers explain what makes a selection of stories they read in other publications ...

Whether the next pandemic is caused by H5N1 bird flu or something else, we must prepare now to use convalescent plasma to ...

STAT '3 to Watch' series looks at biotech industry issues in 2025: Trump administration uncertainties, pharma deals in China, ...

Retractions are meant to maintain trust in science — but on social media, they're often used to reinforce anti-science bias ...

Bone marrow transplants, long a mainstay of blood cancer treatments, are becoming less common in favor of options like CAR-T ...

One of those experts was Stanley Biber, a pioneer of vaginoplasties in the U.S. and perhaps the country’s busiest ...

The killing of UnitedHealthcare CEO Brian Thompson has sparked extraordinary public interest in the nation’s health insurance ...

After multiple short-term extensions, telehealth providers are eager for Congress to lay out its long-term plans for the ...

Although research and development funding for tuberculosis reached new heights last year, the total fell substantially short of goals set by the United Nations and most of the increase came from ...

It is time for us to dispel the darkness of our health care industry through the light of integrity and compassion,” writes ...

Reports that cows have been infected despite farmers' preventive measures indicate there are multiple routes of transmission ...